Hypothalamic Diseases

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Irvine, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — La Jolla, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Palo Alto, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — New Haven, Connecticut, United States

• Pfizer Investigational Site — Besançon, France
• Pfizer Investigational Site — Bordeaux, France
• Pfizer Investigational Site — Dunkirk, France
• Pfizer Investigational Site — Limoges, France

• Clementino Fraga Filho University Hospital — Rio de Janeiro, Brazil

• University of Massachusetts Medical School — Worcester, Massachusetts, United States

• Department of Molecular and Clinical Endocrinology and Oncology University Federico II of Naples — Naples, Italy

• Medical Department M, The Medical Research Laboratories, Aarhus University Hospital — Aarhus C, Denmark

• Haemek Medical Center — Afula, Israel

Not specified

• Kansai Medical University — Osaka, Japan

• University of Louisville — Louisville, Kentucky, United States
• University of Texas Medical Branch — Galveston, Texas, United States
• Diabetes and Glandular Disease Clinic — San Antonio, Texas, United States